Transcatheter mitral valve replacement (TMVR) with the Tendyne device reduces heart failure symptoms and improves patients’ quality of life at 1 year in a high-surgical-risk, severe mitral annular calcification (MAC) population, a new study suggests. 

Evolution of PCI & SELUTION SLR Drug-Eluting Balloon

Survival with a left ventricular assist device (LVAD) is at least as good as the heart transplantation pathway once the pre-transplant waiting period is considered in middle-aged and older patients with advanced heart failure (HF), a new analysis suggests. 

Patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve have similar 10-year clinical outcomes and mortality rates versus surgery, and patients with AS undergoing TAVR with the SAPIEN XT prosthesis have lower survival rates versus surgery, long-term data from randomized clinical trials show. 

Valvular heart disease (VHD) is widespread, and the number of patients with VHD is growing, heart experts say as they weigh in on the prevalence of VHD in older adults across the U.S. 

A new study reveals a link between intensive lifestyle intervention and a lower long-term risk of multimorbidity in adults with prediabetes, with researchers noting that metformin shows no significant benefit compared with placebo. 

New study findings suggest that patients with atrial fibrillation (AF) who reported improvements in health status during the first year after diagnosis or referral for management have a significantly lower risk of subsequent adverse clinical outcomes. 

Management of ISR - SELUTION4ISR Clinical Trial

A reperfusion-guided systolic blood pressure strategy improves 90-day functional outcomes after successful endovascular therapy for acute ischemic stroke, new randomized trial data suggest.